neuroendocrine tumors

You have access
An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 1: Design and Early Results of the SNMMI Dosimetry Challenge
Carlos Uribe, Avery Peterson, Benjamin Van, Roberto Fedrigo, Jake Carlson, John Sunderland, Eric Frey and Yuni K Dewaraja

Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 36S-47S; DOI: https://doi.org/10.2967/jnumed.121.262748
You have access
Quantitative ⁶⁸Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with ¹⁷⁷Lu-DOTATATE
Claudia Ortega, Rebecca K.S. Wong, Josh Schaefferkoetter, Patrick Veit-Haibach, Sten Myrehaug, Rosalyn Juergens, David Laidley, Reut Anconina, Amy Liu and Ur Metser

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1406-1414; DOI: https://doi.org/10.2967/jnumed.120.256727
You have access
¹⁸F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up Study
Tina Binderup, Ulrich Knigge, Camilla Bardram Johnbeck, Annika Loft, Anne Kiil Berthelsen, Peter Oturai, Jann Mortensen, Birgitte Federspiel, Seppo W. Langer and Andreas Kjaer

Journal of Nuclear Medicine June 1, 2021, 62 (6) 808-815; DOI: https://doi.org/10.2967/jnumed.120.244798
You have access
Intraarterial Peptide Receptor Radionuclide Therapy Using ⁹⁰Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors
Courtney Lawhn-Heath, Nicholas Fidelman, Bryant Chee, Salma Jivan, Evan Armstrong, Li Zhang, Sheila Lindsay, Emily K. Bergsland and Thomas A. Hope

Journal of Nuclear Medicine February 1, 2021, 62 (2) 221-227; DOI: https://doi.org/10.2967/jnumed.119.241273
You have access
Inflammation-Based Index and ⁶⁸Ga-DOTATOC PET–Derived Uptake and Volumetric Parameters Predict Outcome in Neuroendocrine Tumor Patients Treated with ⁹⁰Y-DOTATOC
Elin Pauwels, Sofie Van Binnebeek, Vincent Vandecaveye, Kristof Baete, Hubert Vanbilloen, Michel Koole, Felix M. Mottaghy, Karin Haustermans, Paul M. Clement, Kristiaan Nackaerts, Eric Van Cutsem, Chris Verslype and Christophe M. Deroose

Journal of Nuclear Medicine July 1, 2020, 61 (7) 1014-1020; DOI: https://doi.org/10.2967/jnumed.119.236935
You have access
⁶⁴Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor–Positive Neuroendocrine Tumors: Results of the First U.S. Prospective, Reader-Masked Clinical Trial
Ebrahim S. Delpassand, David Ranganathan, Nilesh Wagh, Afshin Shafie, Ayman Gaber, Ali Abbasi, Andreas Kjaer, Izabela Tworowska and Rodolfo Núñez

Journal of Nuclear Medicine June 1, 2020, 61 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.119.236091
Open Access
Efficacy and Safety of High-Specific-Activity ¹³¹I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Daniel A. Pryma, Bennett B. Chin, Richard B. Noto, Joseph S. Dillon, Stephanie Perkins, Lilja Solnes, Lale Kostakoglu, Aldo N. Serafini, Miguel H. Pampaloni, Jessica Jensen, Thomas Armor, Tess Lin, Theresa White, Nancy Stambler, Stuart Apfel, Vincent A. DiPippo, Syed Mahmood, Vivien Wong and Camilo Jimenez

Journal of Nuclear Medicine May 1, 2019, 60 (5) 623-630; DOI: https://doi.org/10.2967/jnumed.118.217463
You have access
Twelve-Year Follow-up After Peptide Receptor Radionuclide Therapy
Michael Gabriel, Bernhard Nilica, Bernhard Kaiser and Irene J. Virgolini

Journal of Nuclear Medicine April 1, 2019, 60 (4) 524-529; DOI: https://doi.org/10.2967/jnumed.118.215376
You have access
Safety, Biodistribution, and Radiation Dosimetry of ⁶⁸Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
Guillaume P. Nicolas, Seval Beykan, Hakim Bouterfa, Jens Kaufmann, Andreas Bauman, Michael Lassmann, Jean Claude Reubi, Jean E.F. Rivier, Helmut R. Maecke, Melpomeni Fani and Damian Wild

Journal of Nuclear Medicine June 1, 2018, 59 (6) 909-914; DOI: https://doi.org/10.2967/jnumed.117.199737
You have access
Sensitivity Comparison of ⁶⁸Ga-OPS202 and ⁶⁸Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
Guillaume P. Nicolas, Nils Schreiter, Felix Kaul, John Uiters, Hakim Bouterfa, Jens Kaufmann, Tobias E. Erlanger, Richard Cathomas, Emanuel Christ, Melpomeni Fani and Damian Wild

Journal of Nuclear Medicine June 1, 2018, 59 (6) 915-921; DOI: https://doi.org/10.2967/jnumed.117.199760

Main menu

User menu

Search

neuroendocrine tumors

Pages